Estimating the variance of cancer prevalence from population-based registries

Statistical Methods in Medical Research

Volumn 15, Issue 3, 2006, Pages 235-253

  Gigli, Anna ^a   Mariotto, Angela ^b   Clegg, Limin X ^b   Tavilla, Andrea ^c   Corazziari, Isabella ^c   Capocaccia, Riccardo ^c   Hachey, Mark ^d   Scoppa, Steve ^d  

^a Istituto Di Ricerche Sulla Popolazione E Le Politiche Sociali Rome   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; BREAST CANCER; CALCULATION; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RESEARCH; CANCER SURVIVAL; CANCER SURVIVOR; COLON CANCER; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NONPARAMETRIC TEST; OBSERVATIONAL METHOD; PARAMETRIC TEST; PREDICTION; PREVALENCE; PROBABILITY; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; VARIANCE;

ADULT; AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); COLONIC NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREVALENCE; REGISTRIES; SEER PROGRAM;

EID: 33744828508     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/0962280206sm427oa     Document Type: Article

References (25)

1. Verdecchia A, Capocaccia R, Egidi V, Golini A. A method for the estimation of chronic disease morbidity and trends from mortality data. Statistics in Medicine 1989; 8: 201-16.
2. Keiding N. Age-specific incidence and prevalence: a statistical perspective. Journal of the Royal Statistical Society, Series A 1991; 154: 371-412.
3. Gail MH, Kessler L, Midthune D, Scoppa S. Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics 1999; 55: 1137-44.
4. Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer: estimates based on the Connecticut Cancer registry. New England Journal of Medicine 1986; 315: 1394-97.
5. Krogh V, Micheli A. Measure of cancer prevalence with a computerized program: an example on larynx cancer. Tumori 1996; 82: 287-90.
6. Surveillance, Epidemiology, and End Results Program. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. From http://www.seer.cancer.gov [released April 2003, based on the November 2002 submission].
7. Surveillance Research Program. National Cancer Institute SEER*Stat Software. (n.d.), from, http://www.seer.cancer.gov/seerstat [Version 5.1.14].
8. Clegg LX, Gail MH, Feuer EJ. Estimating the variance of disease-prevalence estimates from population-based registries. Biometrics 2002; 55: 1137-44.
9. Capocaccia R, De Angelis R. Estimating the completeness of prevalence based on cancer registry data. Statistics in Medicine 1997; 16: 425-40.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457-81.
11. Capocaccia R. Relationships between incidence and mortality in non-reversible diseases. Statistics in Medicine 1993; 12: 2395-415.
12. Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. International Journal of Epidemiology 2000; 29: 197-207.
13. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. British Journal of Cancer 1954; 8: 1-15.
14. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. National Cancer Institute Monography 1961; 6: 101-21.
15. Goldman A. Survivorship analysis when cure is a possibility: a Monte Carlo study. Statistics in Medicine 1984; 3: 153-63.
16. De Angelis R, Capocaccia R, Hakulinen T, Soderman B, Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Statistics in Medicine 1999; 18: 441-54.
17. Eurocare Working Group (Editors) Eurocare-3: the survival of cancer patients diagnosed in Europe during 1990-94. Annals of Oncology 2003; 14: Supplement 5.
18. Gigli A, Verdecchia A. Uncertainty of AIDS incubation time and its effects on backcalculation estimates. Statistics in Medicine 2000; 19: 175-89.
19. Temkin NR. An analysis for transient states with application to tumor shrinkage. Biometrics 1978; 34: 571-80.
20. Begg CB, Larson M. A study of the use of the probability-of-being-in-response function as a summary of tumor response data. Biometrics 1982; 38: 59-66.
21. Pepe MS, Longton G, Thornquist M. A qualifier Q for the survival function to describe the prevalence of a transient condition. Statistics in Medicine 1991; 10: 413-21.
22. Couper D, Pepe MS. Modelling prevalence of a condition: chronic graft-versus-host disease after bone marrow transplantation. Statistics in Medicine 1997; 16: 1551-71.
23. Verdecchia A, De Angelis G, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Statistics in Medicine 2002; 21: 3511-26.
24. Mariotto A, Capocaccia R, Verdecchia A, Micheli A, Feuer EJ, Pickle L, Clegg LX. Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes and Control 2002; 13: 101-11.
25. Stoer J, Bulirsch R. Introduction to numerical analysis. Springer, 1991.